HHS-2019 ApS: Financial statements 2022
CVR: 40428941
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HHS-2019 ApS (CVR 40428941) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -12,306 and a net result of DKK 44,126 compared with DKK -83,495 the year before. Equity in the 2022 report amounted to DKK 84,777. The solvency ratio was 38.8%.
- Gross Profit
- DKK -12,306
- Profit/Loss
- DKK 44,126
- Equity
- DKK 84,777
- Total Assets
- DKK 218,522
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -12 t. | 44 t. | 85 t. | - |
| 2021 | - | -12 t. | -83 t. | 41 t. | - |
| 2020 | - | -6 t. | 130 t. | 124 t. | 0 |
Official annual report
Keep an eye on HHS-2019 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HHS-2019 ApS has published its annual report for 2021. Gross profit came to DKK -12,310, and the net result was DKK -83,495.
About HHS-2019 ApS
HHS-2019 ApS was a Danish company of the type Anpartsselskab based in Kastrup, founded in 2019. The company has been dissolved on 20 December 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named HHS-2019 IVS and Integra 4 08042019 IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2022, the company reported a gross profit of DKK -12,306 and a net result of DKK 44,126 compared with DKK -83,495 the year before. Equity in the 2022 report amounted to DKK 84,777.